Abstract:We recently demonstrated PNAS-2 serving as both an anti-apoptotic gene and an oncogene which is specifically up-regulated in acute leukemic patients (Hai-Rong WANG, et al. Oncology, Accepted). However, its role in apoptotic pathway remains elusive. Antibody microarray was applied to study the apoptosis-associated proteins' changes to elucidate its role in apoptotic pathway. After PNAS-2 was inhibited by RNA interference, caspase3 was up-regulated confirming that PNAS-2 had an anti-apoptotic function. The activation of extrinsic, receptor-mediated apoptotic pathway was characterized by binding a death ligand to the corresponding death receptor. In this study, there were no changes in TNFα, CD95/Fas, TNFR, FADD, TRADD and caspase8 though Fas ligand decreased, while the apoptotic inhibitors such as DcR1 and FLIP were up-regulated, indicating there was no activation in the extrinsic apoptotic pathway. As to the apoptogenic proteins of classical intrinsic apoptotic pathway, there were no changes in Bax and caspase 9 though Bim was down-regulated, while the apoptotic inhibitors such as Bcl-2, Bcl-XL were up-regulated, indicating there was no activation in the intrinsic apoptotic pathway as well. Apart from the two classical apoptotic pathways (intrinsic and extrinsic), Granzyme B (GraB)-perforin apoptotic pathway is one well defined extrinsic accessory way of triggering apoptosis. In our data, GraB and Perforin were up-regulated, suggesting the GraB-Perforin apoptotic pathway was also activated. The apoptosis-induced factor (AIF) and Cathepsin D (CatD) were also up-regulated. AIF could induce apoptosis via a caspase-independent pathway, and Cat D could selectively escape AIF from mitochondria when translocated into the cytosol from lysosome, while other apoptogenic proteins resided in the intermembrane space of mitochondria such as cytochrome c and endonuclease G remained in the mitochondria (Nicolas Bidere, et al. JBC, 2003). Our data indicated that the AIF-induced-caspase-independent pathway was activated when PNAS-2 was inhibited. The changes in protein levels of CatD, AIF and GraB were confirmed by Western Blot. Mannose-6-Phosphate receptor (M6Pr) is the target receptor for GraB and CatD, mediating uptake of the proteases to form vesicles via endocytosis. This receptor also serves to transport newly synthesized GraB and CatD into the vesicles. The vesicles would form a structure named multivesicular body (MVB), which served to sort vesicles' content destined for degradation or routing to the lysosome. CHMP5 (the alias of PNAS-2) located in MVB and lysosome, and the loss of CHMP5/PNAS-2 could inhibit lysosomal degradation (Jae-Hyuck Shim, et al. JCB, 2006). As GraB and CatD could trigger apoptosis when they were effluxed from the lysosome, we hypothesize that the overexpression of PNAS-2 in leukemic patients might execute its anti-apoptotic function by increasing the lysosomal degradation of apoptogenic factors in lysosome such as CatD and GraB.

The Role Of Pnas-2 In Apoptotic Pathway

PNAS-2’s Subcullar Location in Leukemic Cell is Abnormal and Its Relation with Leukemogenesis.

EAPF/Phafin-2, a Novel Endoplasmic Reticulum-Associated Protein, Facilitates TNF-α-triggered Cellular Apoptosis Through Endoplasmic Reticulum-Mitochondrial Apoptotic Pathway

Acetyl-Coenzyme A acyltransferase 2 attenuates the apoptotic effects of BNIP3 in two human cell lines.

PNAS-2: a novel gene probably participating in leukemogenesis.

Role of Phosphatidylinositol 3-Kinase and Specific Protein Kinase B Isoforms in the Suppression of Apoptosis Mediated by the Abelson Protein-tyrosine Kinase

Effects of anti-PNAS-2 single chain antibody on apoptosis of human leukemic U937 cells

NPAS2 regulates proliferation of acute myeloid leukemia cells via CDC25A-mediated cell cycle progression and apoptosis.

A study on apoptosis-related gene changes using genechip after the suppression of PNAS-2 expression by RNA interference

Acidic Leucine-Rich Nuclear Phosphoprotein 32 Family Member B (ANP32B), a Novel Caspase-3 Substrate, Exerts Anti-Apoptotic Effects on Acute Myeloid Leukemic Cells.

Association of Caspase-2 with the Promyelocytic Leukemia Protein Nuclear Bodies

Downregulation of ANP32B, a Novel Substrate of Caspase-3, Enhances Caspase-3 Activation and Apoptosis Induction in Myeloid Leukemic Cells

Influence of Apoptin on Up-Regulation of the Expression of Bad and Bax

Caspase-3-resistant uncleavable form of acidic leucine-rich nuclear phosphoprotein 32B potentiates leukemic cell apoptosis.

Altered Protein-Expressing Profile in Hpnas4-Induced Apoptosis in A549 Human Lung Adenocarcinoma Cells

Protein Phosphatase 2A Inhibitors Activate Extrinsic Apoptosis in Pancreatic Cancer Cells Through Nuclear Factor-Κb Dependent Pathway

The Role of Charged Multivesicular Body Protein 5 in Programmed Cell Death in Leukemic Cells

Apoptosis Ratio Changes of U937 after Inhibition of PNAS-2 by RNA Interference

Involvement of General Control Nonderepressible Kinase 2 in Cancer Cell Apoptosis by Posttranslational Mechanisms.

Human ACAP2 is a Homolog of C. Elegans CNT-1 That Promotes Apoptosis in Cancer Cells.

[Expression spectra of apoptosis-related gene pnas-2].